New post-hoc analysis shows daily oral weight loss / diabetes medication orforglipron was associated with similar weight reductions for women of different menopausal status
New analyses to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) show… read more.
